Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amar Patel, MD
Celgene
Study Director - Ezra Cohen, MD
University of Chicago
Study Chair - Robert Ferris, MD, PhD
University of Pittsburgh
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
53 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Tower Hematology Oncology Medical Group
Beverly Hills, California, United States
- California Cancer Associates for Research and Excellence (ccare)
Escondido, California, United States
- University of California San Diego Moores Cancer Center
La Jolla, California, United States
- University of California Norris Comprehensive Cancer Center
Los Angeles, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Va Eastern Colorado Healthcare System
Denver, Colorado, United States
- Helen F. Graham Cancer Center
Newark, Delaware, United States
- Md Anderson Cancer Center
Orlando, Florida, United States
- Northeast Georgia Cancer Care, Llc
Athens, Georgia, United States
- Winship Cancer Institute
Atlanta, Georgia, United States
- Tripler Army Medical Center
Honolulu, Hawaii, United States
- Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- University of Kansas Cancer Center
Westwood, Kansas, United States
- Crescent City Research Consortium, Llc
Marrero, Louisiana, United States
- Robert W. Veith, Md, Llc
Metairie, Louisiana, United States
- Maine Center for Cancer Medicine
Scarborough, Maine, United States
- the Sidney Kimmel Comprehensive Cancer Center at John Hopkins
Baltimore, Maryland, United States
- Walter Reed National Military Medical Center
Bethesda, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Karmanos Cancer Institute
Detroit, Michigan, United States
- Providence Cancer Institute
Southfield, Michigan, United States
- Saint Louis Cancer Care, Llp
Bridgeton, Missouri, United States
- Barnes Jewish Hospital
St Louis, Missouri, United States
- Nevada Cancer Research Foundation
Las Vegas, Nevada, United States
- Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Oncology and Hematology Specialists, P.A.
Denville, New Jersey, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Monter Cancer Center
Lake Success, New York, United States
- Mount Sinai Medical Center
New York, New York, United States
- the Bellevue Hospital
New York, New York, United States
- Stony Brook University Medical Center
Stony Brook, New York, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University Hospitals of Cleveland
Cleveland, Ohio, United States
- Saint Charles Medical Center
Bend, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Oct 2013
- Primary completion
- 13 Apr 2016
- Completion
- 19 Sept 2016
- Last update posted
- 29 Oct 2019
- Registered enrollment
- 195
- Registry id
- NCT01836029
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.